Anavo Therapeutics BV
Roman Maresch is an experienced cancer cell biologist currently working at Anavo Therapeutics BV since February 2022. Prior to this role, Roman served as a postdoctoral researcher at Klinikum rechts der Isar from October 2018 to January 2022. Roman's academic journey includes earning a PhD at DKFZ, where research was conducted from August 2013 to September 2018.
This person is not in any offices
Anavo Therapeutics BV
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavois developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications